BioSpace News Archive

NKMax America announced that the U.S. Food and Drug Administration has accepted the Investigational New Drug application for SNK01, an autologous NK cell adoptive immunotherapy candidate for the treatment of patients with pathologically confirmed cancer refractory to conventional therapy.

Neovasc Inc. announced that an implant procedure of the Neovasc Reducer™ was featured in a “Live Case” broadcast at the Cardiovascular Research Technologies meeting being held March 2-5, 2019 in Washington, DC.

Jazz Pharmaceuticals plc announced that the company will be webcasting its corporate presentation at the Cowen and Company 39th Annual Healthcare Conference in Boston, MA.

Enzo Biochem, Inc. will hold a conference call to discuss fiscal 2019 second quarter results Tuesday, March 12, 2019, at 8:30 AM E.T.

Seres Therapeutics, Inc. announced that it will present at each of the following upcoming healthcare conferences

Ended 2018 with four molecules in clinical development, including AB928, the Company’s dual A2aR/A2bR receptor antagonist, which is being evaluated in several dose-escalation trials in combination with chemotherapy or AB122 (anti-PD-1 antibody)

Cerus Corporation announced the appointment of Jami Nachtsheim to its Board of Directors. Ms. Nachtsheim currently serves on the Board at Intuitive Surgical, the global market leader in robotic-assisted minimally invasive surgical systems.

Gilead Sciences, Inc. announced that Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami on Tuesday, March 12 at 10:45 a.m. Eastern Time.

Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Cowen 39th Annual Health Care Conference in Boston, MA on Tuesday, March 12, 2019 at 11:20 a.m., ET.

Current Board Member Tim Pearson to become Board Chair effective at the close of the company’s annual meeting on May 17, 2019